Predicted protein targets (top 8)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | SIRT5 | Q9NXA8 | 3/20 | 0.58 |
| ▸ | SIRT2 | Q8IXJ6 | 13/20 | 0.57 |
| ▸ | SIRT1 | Q96EB6 | 12/20 | 0.57 |
| ▸ | SIRT3 | Q9NTG7 | 3/20 | 0.57 |
| ▸ | CTSS | P25774 | 1/20 | 0.54 |
| ▸ | CTSK | P43235 | 1/20 | 0.54 |
| ▸ | KLK7 | P49862 | 1/20 | 0.52 |
| ▸ | KLK5 | Q9Y337 | 1/20 | 0.52 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL5307836 | 1.00 | SIRT5 (0.58) | SIRT5SIRT2SIRT1SIRT3CTSS | |
| SCHEMBL8245893 | 1.00 | SIRT5 (0.58) | SIRT5SIRT2SIRT1SIRT3CTSS | |
| SCHEMBL8246035 | 0.94 | CTSS (0.56) | SIRT5SIRT2SIRT1SIRT3CTSS | |
| SCHEMBL5301318 | 0.94 | CTSS (0.56) | SIRT5SIRT2SIRT1SIRT3CTSS | |
| SCHEMBL5308048 | 0.91 | SIRT5 (0.59) | SIRT5SIRT2SIRT1SIRT3 | |
| SCHEMBL8244805 | 0.91 | SIRT5 (0.59) | SIRT5SIRT2SIRT1SIRT3 | |
| SCHEMBL17039831 | 0.86 | SIRT5 (0.61) | SIRT5SIRT2SIRT1SIRT3KLK7 | |
| SCHEMBL5333249 | 0.85 | CTSL (0.56) | SIRT5SIRT2SIRT1SIRT3CTSK | |
| SCHEMBL8247728 | 0.85 | CTSL (0.56) | SIRT5SIRT2SIRT1SIRT3CTSK | |
| SCHEMBL4857149 | 0.85 | MAPT (0.58) | SIRT2SIRT1SIRT3CTSSCTSK |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| WO-2007027742-A2 | SMALL MOLECULE INTEGRIN α2βl/GPIa-IIa ANTAGONISTS | THE TRUSTEES OF THE UNIVERSITY OF PENNSYLVANIA (US) | 2007-03-08 | — | — | WO | disclosed |